How I treat Logo
howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Congenital Dyserythropoietic Anemia

It is group of disorders characterized by

  • Anemia which is noted in infancy or childhood (Macrocytic normochromic)
  • Presence of multinuclear erythroid precursors in bone marrow
  • Ineffective erythropoiesis due to intramedullary cell death
  • Normal myelopoiesis and megakaryopoiesis
  • Iron overload with raised ferritin
  • Splenomegaly is often present
  • Unconjugatedhyperbilirubinemia

 

CDA-I

  • Autosomal recessive inheritance
  • Mutation of CDAN1 gene located on 15q13 leading to decreased codanin which is cell cycle regulatory protein
  • Defect in nucleoprotein/ nuclear membrane.
  • Associated dysmorphic features are
    • Syndactyly
    • Hypoplasia of phalanges
    • Supplementary metatarsal
    • Club foot
    • Small stature
    • Almond shaped blue eyes
    • Hypertelorism
    • Micrognathism
    • Patches of brown skin pigmentation
    • Pigeon chest deformity
    • Varus deformity of hips
    • Flattened vertebral bodies
    • Congenital ptosis
    • Madelung deformity of wrist
    • Deafness
  • Peripheral smear: Marked poikilocytosis and Cabbot's rings
  • Hemoglobin level- 6-11 gm/dL
  • Bone marrow shows megaloblasts and binucleated erythroblasts (incomplete division of nuclear segments) with internuclear chromatin bridges.
  • Electron microscopy shows “Swiss cheese” nuclear abnormality.  (Widened nuclear pores with spongy appearance of heterochromatin, invasion by cytoplasm containing various organelle)
  • Decreased RBC membrane protein 4.1R
  • Prognosis: Severe forms present with hydropsfetalis

 

CAD-II (HEMPAS = Hereditary erythroblasticMultinuclearity with positive acidified serum test)

  • Autosomal recessive inheritance.
  • Most common form of CDA.
  • Etiopathogenesis

Mutation of SEC23B gene on chromosome 20p11

Deficiency of α-mannosidase II N-acetyl glucosaminyltransferase II

Defect in glycosylation pathway

Abnormalities in glycoprotein bands 3 and 5.5 and Glycophorin A

Defective vesicle trafficking between endoplasmic reticulum and golgi apparatus

  • Transfusion dependence is uncommon
  • Peripheral smear: Anisocytosis, anisochromia, spherocytes
  • Bone marrow
    • Erythroblasts show multinuclearity (up to7)- Seen in 10-30% of erythroblasts
    • Pleuripolar mitosis and karyorrhexis are seen
    • Pseudogoucher cells are seen
  • Ham’s (Acidified serum) test- Positive.(Unlike in PNH, hemolysis is seen with acidified normal serum but not by patient’s own serum)
  • Sucrose hemolysis test – Negative.
  • Electron microscopy - peripheral arrangement of endoplasmic reticulum giving appearance of double membrane.
  • Clinical features  
    • Anemia at birth
    • Variable degree of jaundice.
    • Hepatomegaly, splenomegaly
    • Cirrhosis.
    • Diabetes.

 

CDA-III

  • Autosomal dominant inheritance.
  • Giant erythroblasts measuring up to 50microns are seen which contain up to 16 nuclei. They contain coarse basophilic granules.
  • Clinically mild form
  • They have tendency to develop retinal angioid streaks and myeloma
  • Electron microscopy- Clefts and blebs in nuclear area, Some iron filled mitochondria, autophagic vacuoles and myeline figures in cytoplasm

 

Treatment of CDA

  • Blood transfusion (As minimum as possible) with chelation therapy once ferritin crosses 1000.
  • If anemia is moderate and well compensated, periodic phlebotomy may be used to decrease the iron load
  • Folic acid supplementation 
  • Splenectomy for transfusion depended cases  (useful in CAD II)
  • INF-α (useful in CAD-I)
  • Bone marrow transplantation

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo
howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.